Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
27.97
+0.27 (0.97%)
At close: Dec 8, 2025, 4:00 PM EST
27.69
-0.28 (-1.00%)
Pre-market: Dec 9, 2025, 5:18 AM EST
Moderna Market Cap
Moderna has a market cap or net worth of $10.93 billion as of December 9, 2025. Its market cap has decreased by -23.12% in one year.
Market Cap
10.93B
Enterprise Value
5.02B
1-Year Change
-23.12%
Ranking
Category
Stock Price
$27.97
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $10.93B, an increase of 78.62%. That is a compound annual growth rate of 8.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 8, 2025 | 10.93B | -31.70% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | 41.34B | 534.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 893.23B |
| Johnson & Johnson | 485.76B |
| AbbVie | 394.34B |
| UnitedHealth Group | 293.15B |
| AstraZeneca | 280.30B |
| Novartis AG | 253.21B |
| Merck & Co. | 245.55B |
| Thermo Fisher Scientific | 213.48B |